Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion

Kayseri Education and Research Hospital

Status: Completed

Conditions: Pain

Treatments: Drug: Lidocaine Spray; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT02020551

kerhGA

Details and patient eligibility

About

Pain during intrauterine device (IUD) insertion can be a barrier to initiation. Misoprostol and nonsteroidal drugs have found to be ineffective by clinical trials.Investigators tested whether intracervical 2% lidocaine gel decreased insertion pain compared to placebo.

Enrollment: 223 patients

Sex: Female

Ages: 18 to 49 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Age >18 Not pregnant Smear negative

Exclusion criteria

Chronic pelvic pain Pregnancy Uterine anomaly Fibroid Acute cervicitis Pelvic inflammatory disease Cervical stenosis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

223 participants in 2 patient groups, including a placebo group

saline spray application

Placebo Comparator group

Description:

Placebo group

Treatment:

Drug: Placebo

lidocaine spray application

Experimental group

Description:

2 puff lidocaine spray applicated before IUD insertion

Treatment:

Drug: Lidocaine Spray